ProShares UltraShort Bloomberg Natrl Gas

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily Gold Miners Bull 3X ETF

Direxion Daily 20+ Yr Trsy Bull 3X ETF

VanEck Vectors Junior Gold Miners ETF

Bank Of Montreal

Direxion Daily Technology Bull 3X ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

VanEck Vectors Gold Miners ETF

Direxion Daily Financial Bull 3X ETF

ProShares Ultra Bloomberg Natural Gas

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

United States Natural Gas

Direxion Daily Gold Miners Bear 3X ETF

Direxion Daily 20+ Yr Trsy Bear 3X ETF

Direxion Technology Bear 3X Shares

Direxion Dly S&P Oil&Gs Ex&Prd Bl 3X ETF

Direxion Financial Bear 3X Shar

Juniper Networks Inc. Common Stock

Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share)

Reddit Inc. Class A Common Stock

Carvana Co. Class A Common Stock

Whirlpool Corporation Common Stock

New Gold Inc.

Oracle Corporation Common Stock

Alamos Gold Inc. Class A Common Shares

Archer Aviation Inc. Class A Common Stock

First Majestic Silver Corp. Ordinary Shares (Canada)

ChargePoint Holdings Inc. Common Stock

WESCO International Inc. Common Stock

RE/MAX Holdings Inc. Class A Common Stock

Leggett & Platt Incorporated Common Stock

Quaker Houghton Common Stock

US Foods Holding Corp. Common Stock

Boyd Gaming Corporation Common Stock

Boeing Company (The) Common Stock

Asbury Automotive Group Inc Common Stock

Olin Corporation Common Stock

Click here to get full coverage on Immunome (IMNM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Immunome (IMNM) Upgraded to Buy: Here's What You Should Know  Yahoo Finance

Immunome (IMNM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Click here to get full coverage on Cancer Therapy Developer Immunome Set for TD Cowen and Goldman Sachs Healthcare Conferences - Stock Titan

Cancer Therapy Developer Immunome Set for TD Cowen and Goldman Sachs Healthcare Conferences  Stock Titan

Cancer Therapy Developer Immunome Set for TD Cowen and Goldman Sachs Healthcare Conferences - Stock Titan

Click here to get full coverage on Immunome: Transformed Pipeline Offers Multiple Catalysts (NASDAQ:IMNM) - Seeking Alpha

Immunome: Transformed Pipeline Offers Multiple Catalysts (NASDAQ:IMNM)  Seeking Alpha

Immunome: Transformed Pipeline Offers Multiple Catalysts (NASDAQ:IMNM) - Seeking Alpha

Click here to get full coverage on IMNM： Integrated Multi-Network Model for Identifying Pepper Leaf Diseases - Frontiers

IMNM： Integrated Multi-Network Model for Identifying Pepper Leaf Diseases  Frontiers

IMNM： Integrated Multi-Network Model for Identifying Pepper Leaf Diseases - Frontiers

Click here to get full coverage on Immunome Announces Pricing of Upsized Public Offering of Common Stock - Business Wire

Immunome Announces Pricing of Upsized Public Offering of Common Stock  Business Wire

Immunome Announces Pricing of Upsized Public Offering of Common Stock - Business Wire

Click here to get full coverage on Wall Street Analysts Think Immunome (IMNM) Could Surge 188.57%: Read This Before Placing a Bet - Yahoo Finance

Wall Street Analysts Think Immunome (IMNM) Could Surge 188.57%: Read This Before Placing a Bet  Yahoo Finance

Wall Street Analysts Think Immunome (IMNM) Could Surge 188.57%: Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on Insider Purchase: Director at $IMNM Buys 7,800 Shares - Nasdaq

Insider Purchase: Director at $IMNM Buys 7,800 Shares  Nasdaq

Insider Purchase: Director at $IMNM Buys 7,800 Shares - Nasdaq

Click here to get full coverage on Immunome Secures Nearly $400M War Chest as Phase 3 Trial Hits Key Milestone - Stock Titan

Immunome Secures Nearly $400M War Chest as Phase 3 Trial Hits Key Milestone  Stock Titan

Immunome Secures Nearly $400M War Chest as Phase 3 Trial Hits Key Milestone - Stock Titan

Click here to get full coverage on Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Business Wire

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Click here to get full coverage on Monday 3/31 Insider Buying Report: IMNM - Nasdaq

Monday 3/31 Insider Buying Report: IMNM  Nasdaq

Monday 3/31 Insider Buying Report: IMNM - Nasdaq

Click here to get full coverage on Immunome Announces Proposed Public Offering of Common Stock - Business Wire

Immunome Announces Proposed Public Offering of Common Stock  Business Wire

Immunome Announces Proposed Public Offering of Common Stock - Business Wire

Click here to get full coverage on Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Business Wire

Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares  Business Wire

Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Business Wire

Click here to get full coverage on Immunome, Inc. (IMNM) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Immunome, Inc. (IMNM) Reports Q4 Loss, Misses Revenue Estimates  Yahoo Finance

Immunome, Inc. (IMNM) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference - Business Wire

Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference  Business Wire

Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference - Business Wire

Click here to get full coverage on Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire

Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update  Business Wire

Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire

Click here to get full coverage on Immunome Can Take The Fight To Competitors With Varegacestat (NASDAQ:IMNM) - Seeking Alpha

Immunome Can Take The Fight To Competitors With Varegacestat (NASDAQ:IMNM)  Seeking Alpha

Immunome Can Take The Fight To Competitors With Varegacestat (NASDAQ:IMNM) - Seeking Alpha

Click here to get full coverage on Immunome Provides Pipeline Update in Advance of Presentation at the 43 - Business Wire

Immunome Provides Pipeline Update in Advance of Presentation at the 43  Business Wire

Immunome Provides Pipeline Update in Advance of Presentation at the 43 - Business Wire

Click here to get full coverage on Immunome Expands Share Reserve in Inducement Plan - TipRanks

Immunome Expands Share Reserve in Inducement Plan  TipRanks

Immunome Expands Share Reserve in Inducement Plan - TipRanks

Click here to get full coverage on 3 Small-Cap Stocks With Big Growth Potential - MarketBeat

3 Small-Cap Stocks With Big Growth Potential  MarketBeat

3 Small-Cap Stocks With Big Growth Potential - MarketBeat

Click here to get full coverage on Immunome stock hits 52-week low at $5.5 amid market challenges - Investing.com

Immunome stock hits 52-week low at $5.5 amid market challenges  Investing.com

Immunome stock hits 52-week low at $5.5 amid market challenges - Investing.com

Click here to get full coverage on Insider Buying: Jean Bienaime Acquires Additional Shares of Immu - GuruFocus

Insider Buying: Jean Bienaime Acquires Additional Shares of Immu  GuruFocus

Insider Buying: Jean Bienaime Acquires Additional Shares of Immu - GuruFocus

Click here to get full coverage on (IMNM) Investment Report - news.stocktradersdaily.com

(IMNM) Investment Report  news.stocktradersdaily.com

(IMNM) Investment Report - news.stocktradersdaily.com

Click here to get full coverage on (IMNM) Investment Analysis and Advice - news.stocktradersdaily.com

(IMNM) Investment Analysis and Advice  news.stocktradersdaily.com

(IMNM) Investment Analysis and Advice - news.stocktradersdaily.com

Click here to get full coverage on Immunome stock rating cut to Hold by Boral Capital - Investing.com

Immunome stock rating cut to Hold by Boral Capital  Investing.com

Immunome stock rating cut to Hold by Boral Capital - Investing.com

Click here to get full coverage on Immunome Reports First Quarter 2025 Financial Results and Provides Business Update - Business Wire

Immunome Reports First Quarter 2025 Financial Results and Provides Business Update  Business Wire

Immunome Reports First Quarter 2025 Financial Results and Provides Business Update - Business Wire

Click here to get full coverage on Immunome Elects New Directors at Annual Meeting - TipRanks

Immunome Elects New Directors at Annual Meeting  TipRanks

Immunome Elects New Directors at Annual Meeting - TipRanks

Click here to get full coverage on argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies - GlobeNewswire

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies  GlobeNewswire

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies - GlobeNewswire

Click here to get full coverage on Immunome earnings beat by $0.14, revenue topped estimates - Investing.com

Immunome earnings beat by $0.14, revenue topped estimates  Investing.com

Immunome earnings beat by $0.14, revenue topped estimates - Investing.com

Click here to get full coverage on Immunome: A Biotech on the Brink of Breakthroughs with Multiple Clinical Catalysts - AInvest

Immunome: A Biotech on the Brink of Breakthroughs with Multiple Clinical Catalysts  AInvest

Immunome: A Biotech on the Brink of Breakthroughs with Multiple Clinical Catalysts - AInvest

Click here to get full coverage on Management of immune‐mediated necrotizing myopathy - Suh - 2024 - Muscle & Nerve - Wiley Online Library

Management of immune‐mediated necrotizing myopathy - Suh - 2024 - Muscle & Nerve  Wiley Online Library

Management of immune‐mediated necrotizing myopathy - Suh - 2024 - Muscle & Nerve - Wiley Online Library

Click here to get full coverage on Immunome: An Oncology Powerhouse In The Making (NASDAQ:IMNM) - Seeking Alpha

Immunome: An Oncology Powerhouse In The Making (NASDAQ:IMNM)  Seeking Alpha

Immunome: An Oncology Powerhouse In The Making (NASDAQ:IMNM) - Seeking Alpha

Click here to get full coverage on STATIN ASSOCIATED IMMUNE MEDIATED NECROTIZING MYOPATHY (SA-IMNM) AND SUBSEQUENT USE OF NON-STATIN LDL-C LOWERING DRUGS - JACC Journals

STATIN ASSOCIATED IMMUNE MEDIATED NECROTIZING MYOPATHY (SA-IMNM) AND SUBSEQUENT USE OF NON-STATIN LDL-C LOWERING DRUGS  JACC Journals

STATIN ASSOCIATED IMMUNE MEDIATED NECROTIZING MYOPATHY (SA-IMNM) AND SUBSEQUENT USE OF NON-STATIN LDL-C LOWERING DRUGS - JACC Journals

Click here to get full coverage on Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies - BMC Pulmonary Medicine

Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies  BMC Pulmonary Medicine

Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies - BMC Pulmonary Medicine

Click here to get full coverage on Cutaneous involvement in anti-HMGCR positive necrotizing myopathy - ScienceDirect.com

Cutaneous involvement in anti-HMGCR positive necrotizing myopathy  ScienceDirect.com

Cutaneous involvement in anti-HMGCR positive necrotizing myopathy - ScienceDirect.com

Click here to get full coverage on Proposed mechanisms of miR-18a-3p and its target HuR in the IMNM... - researchgate.net

Proposed mechanisms of miR-18a-3p and its target HuR in the IMNM...  researchgate.net

Proposed mechanisms of miR-18a-3p and its target HuR in the IMNM... - researchgate.net

Click here to get full coverage on Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy - ScienceDirect.com

Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy  ScienceDirect.com

Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy - ScienceDirect.com

Click here to get full coverage on The Clinicopathological Distinction Between Seropositive and Seronegative Immune-Mediated Necrotizing Myopathy in China - Frontiers

The Clinicopathological Distinction Between Seropositive and Seronegative Immune-Mediated Necrotizing Myopathy in China  Frontiers

The Clinicopathological Distinction Between Seropositive and Seronegative Immune-Mediated Necrotizing Myopathy in China - Frontiers

Click here to get full coverage on Phenotypical statin-associated immune-mediated necrotizing myositis with histological features of inclusion body myositis - Wiley Online Library

Phenotypical statin-associated immune-mediated necrotizing myositis with histological features of inclusion body myositis  Wiley Online Library

Phenotypical statin-associated immune-mediated necrotizing myositis with histological features of inclusion body myositis - Wiley Online Library

Click here to get full coverage on Identification of feature genes and key biological pathways in immune-mediated necrotizing myopathy: High-throughput sequencing and bioinformatics analysis - ScienceDirect.com

Identification of feature genes and key biological pathways in immune-mediated necrotizing myopathy: High-throughput sequencing and bioinformatics analysis  ScienceDirect.com

Identification of feature genes and key biological pathways in immune-mediated necrotizing myopathy: High-throughput sequencing and bioinformatics analysis - ScienceDirect.com

Click here to get full coverage on Pathophysiology of IMNM. IMNM pathophysiology combines innate risk (HLA... - researchgate.net

Pathophysiology of IMNM. IMNM pathophysiology combines innate risk (HLA...  researchgate.net

Pathophysiology of IMNM. IMNM pathophysiology combines innate risk (HLA... - researchgate.net

Click here to get full coverage on Immunome Announces Completion of Purchase of Assets from Atreca - Business Wire

Immunome Announces Completion of Purchase of Assets from Atreca  Business Wire

Immunome Announces Completion of Purchase of Assets from Atreca - Business Wire

Click here to get full coverage on Immunome (IMNM) Stock Price, News & Analysis - MarketBeat

Immunome (IMNM) Stock Price, News & Analysis  MarketBeat

Immunome (IMNM) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Anti-signal recognition particle positive necrotizing myopathy-sjogren’s syndrome overlap syndrome: a descriptive study on clinical and myopathology features - BMC Musculoskeletal Disorders

Anti-signal recognition particle positive necrotizing myopathy-sjogren’s syndrome overlap syndrome: a descriptive study on clinical and myopathology features  BMC Musculoskeletal Disorders

Anti-signal recognition particle positive necrotizing myopathy-sjogren’s syndrome overlap syndrome: a descriptive study on clinical and myopathology features - BMC Musculoskeletal Disorders

Click here to get full coverage on INVESTIGATION ALERT: Halper Sadeh LLC Investigates KDNY, WMC, AJX, IMNM - GlobeNewswire

INVESTIGATION ALERT: Halper Sadeh LLC Investigates KDNY, WMC, AJX, IMNM  GlobeNewswire

INVESTIGATION ALERT: Halper Sadeh LLC Investigates KDNY, WMC, AJX, IMNM - GlobeNewswire

Click here to get full coverage on Brain Pathology | ISN Neuropathology Journal - Wiley Online Library

Brain Pathology | ISN Neuropathology Journal  Wiley Online Library

Brain Pathology | ISN Neuropathology Journal - Wiley Online Library

Click here to get full coverage on BCMA CAR T therapy facilitates potential autoimmune breakthrough - European Pharmaceutical Review

BCMA CAR T therapy facilitates potential autoimmune breakthrough  European Pharmaceutical Review

BCMA CAR T therapy facilitates potential autoimmune breakthrough - European Pharmaceutical Review

Click here to get full coverage on Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome - GlobeNewswire

Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome  GlobeNewswire

Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome - GlobeNewswire

Click here to get full coverage on Initial laboratory values (CK, ALT, AST, aldolase, LDH, CRP, ESR, and... - researchgate.net

Initial laboratory values (CK, ALT, AST, aldolase, LDH, CRP, ESR, and...  researchgate.net

Initial laboratory values (CK, ALT, AST, aldolase, LDH, CRP, ESR, and... - researchgate.net

Click here to get full coverage on Muscle Involvement Seen in Dermatomyositis With and Without Anti-Mi2 Autoantibodies - Neurology Advisor

Muscle Involvement Seen in Dermatomyositis With and Without Anti-Mi2 Autoantibodies  Neurology Advisor

Muscle Involvement Seen in Dermatomyositis With and Without Anti-Mi2 Autoantibodies - Neurology Advisor

Click here to get full coverage on Representative muscle biopsy of a patient with immune-mediated... - researchgate.net

Representative muscle biopsy of a patient with immune-mediated...  researchgate.net

Representative muscle biopsy of a patient with immune-mediated... - researchgate.net

Click here to get full coverage on Figure 2. Proposed mechanism of immune mediated muscle injury in... - researchgate.net

Figure 2. Proposed mechanism of immune mediated muscle injury in...  researchgate.net

Figure 2. Proposed mechanism of immune mediated muscle injury in... - researchgate.net

Click here to get full coverage on Fig. 2 Muscle pathology of ANM-SRP (× 400). Muscle fibers show necrosis... - researchgate.net

Fig. 2 Muscle pathology of ANM-SRP (× 400). Muscle fibers show necrosis...  researchgate.net

Fig. 2 Muscle pathology of ANM-SRP (× 400). Muscle fibers show necrosis... - researchgate.net

Click here to get full coverage on Erythema nodosum of the patient. Erythematous subcutaneous nodules in... - researchgate.net

Erythema nodosum of the patient. Erythematous subcutaneous nodules in...  researchgate.net

Erythema nodosum of the patient. Erythematous subcutaneous nodules in... - researchgate.net

Click here to get full coverage on Table 3 Summary of creatine kinase (CK) value, glucocorticoid dose, and... - researchgate.net

Table 3 Summary of creatine kinase (CK) value, glucocorticoid dose, and...  researchgate.net

Table 3 Summary of creatine kinase (CK) value, glucocorticoid dose, and... - researchgate.net

Click here to get full coverage on Immunome, Inc. (NASDAQ:IMNM) Receives $23.33 Consensus Price Target from Analysts - Defense World

Immunome, Inc. (NASDAQ:IMNM) Receives $23.33 Consensus Price Target from Analysts  Defense World

Immunome Inc (IMNM)

Price Chart

Key Statistics

Technicals

About IMNM

Latest News

Immunome (IMNM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Cancer Therapy Developer Immunome Set for TD Cowen and Goldman Sachs Healthcare Conferences - Stock Titan

Immunome: Transformed Pipeline Offers Multiple Catalysts (NASDAQ:IMNM) - Seeking Alpha

Advanced Charts

Top Gainers

Top Losers